Sheel Biotech Limited (NSE:SHEEL)

Market Cap	866.00M
Revenue (ttm)	1.11B +8.8%
Net Income	117.56M +10.5%
EPS	6.69 -7.2%
Shares Out	20.35M
PE Ratio	6.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,000
Open	39.30
Previous Close	41.00
Day's Range	39.10 - 43.00
52-Week Range	37.80 - 95.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Sheel Biotech

Sheel Biotech Limited engages in growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants in India. The company offers fruit planting materials, including banana, citrus, pineapple, pomegranate, guava, apple, peach, pear, plum, blueberry, raspberry, strawberry, and other fruit crops; planting material for various forestry species, including bamboo, eucalyptus, poplar, yucca, and others; and various ornamental plants such as bonsai, palms, succulents, and ferns, as well as c...

• Industry: Agricultural Production Crops
• Founded: 1991
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SHEEL

Financial Performance

In fiscal year 2026, Sheel Biotech's revenue was 1.11 billion, an increase of 8.83% compared to the previous year's 1.02 billion. Earnings were 117.56 million, an increase of 10.53%.